Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas

NCT02547350 is registered in ClinicalTrials.gov with Xuesong Li as lead sponsor.

NCT NCT02547350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02547350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
Lead sponsor
Xuesong Li
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2015
Completion date
Not reported
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bladder recurrence, upper tract urothelial carcinoma